Carbapenem-resistant Acinetobacter baumannii (CRAB) remains as a serious cause of infectious diseases and septic mortality in hospitalized patients worldwide. This study was conducted to evaluate the antimicrobial effect of imipenem conjugated silver nanoparticles (AgNPs) on resistant isolated A. baumannii from nosocomial infections.
The antimicrobial susceptibility test of 100 A. baumannii clinical isolates against different antibiotics was performed. PCR was used to confirm bacterial resistance and to identify different genes encoding Ambler class β-lactamases. The chemically synthesized AgNPs were characterized using UV-vis spectroscopy, X-ray diffraction (XRD), transmission electron microscopy (TEM), and Fourier-transform infrared (FTIR). The stability, drug release kinetic, and cytotoxicity (MTT assay) of AgNPs were also investigated. The imipenem were conjugated with AgNPs, and conjugants were characterized as discussed above. Minimum inhibitory concentration (MIC) of the AgNPs and conjugants were tested against A. baumannii isolates and compared with imipenem alone.
The results revealed that among all isolated A. baumannii, 76% showed resistant to imipenem (MIC ≥ 64 μg/mL to ≥ 256 μg/mL). The blaOXA-23, blaPER, blaOXA-40, and blaIMP genes were the most prevalent genes. UV-vis spectroscopy, XRD, TEM, and FTIR analysis confirmed synthesis of AgNPs (average size of 10–40 nm) and conjugation with imipenem. The release of imipenem from AgNPs can be defined as Fickian diffusion model. The MIC values of AgNPs conjugated with imipenem against resistant A. baumannii were decreased in a dose dependent manner and were based on existence of resistant genes. The AgNPs also showed low cytotoxic effects.
The results suggest that imipenem-AgNPs has a strong potency as a powerful antibacterial agent against multi-resistant A. baumannii.
Hammoudi D, Moubareck CA, Hakime N, Houmani M, Barakat A, Najjar Z, Suleiman M, Fayad N, Sarraf R, Sarkis DK (2015) Spread of imipenem-resistant Acinetobacter baumannii co-expressing OXA-23 and GES-11 carbapenemases in Lebanon. Int J Infect Dis 36:56–61. https://doi.org/10.1016/j.ijidCrossRefPubMedGoogle Scholar
Gurunathan S (2014) Rapid biological synthesis of silver nanoparticles and their enhanced antibacterial effects against Escherichia fergusonii and Streptococcus mutans. Arab J Chem. https://doi.org/10.1016/j.arabjc
Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SG, Livermore DM (2006) Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acineto-bacter spp. Int J Antimicrob Agents 27:351–353CrossRefGoogle Scholar
Sarhaddi N, Soleimanpour S, Farsiani F, Mosavat A, Dolatabadi S, Salimizand H, Amel Jamehdar S (2016) Elevated prevalence of multidrug-resistant Acinetobacter baumannii with extensive genetic diversity in the largest burn center of northeast Iran. J Glob Antimicrob Res 8:60–66. https://doi.org/10.1016/j.jgar.2016.10.009CrossRefGoogle Scholar
Bahador A, Raoofian R, Farshadzadeh Z, Beitollahi L, Khaledi A, Rahimi S, Mokhtaran M, Mehrabi-Tavana A, Esmaeili D (2015) The prevalence of ISAba1 and ISAba4 in Acinetobacter baumannii species of different international clone lineages among patients with burning in Tehran, Iran. Jundishapur J Microbiol 8(7):e17167. https://doi.org/10.5812/jjm.17167v2CrossRefPubMedPubMedCentralGoogle Scholar
Wan G, Ruan L, Yin Y, Yang T, Ge M, Cheng X (2016) Effects of silver nanoparticles in combination with antibiotics on the resistant bacteria Acinetobacter baumannii. Int J Nanomedicine 11:3789–3800CrossRefGoogle Scholar
Kazemi D, Salouti M, Rostamizadeh K, Zabihian A (2014) Development of gentamicin-loaded solid lipid nanoparticles: evaluation of drug release kinetic and antibacterial activity against Staphylococcus aureus. Int J Pharmaceut Res Innov 7:1–6Google Scholar
Pourali P, Badiee SH, Manafi S, Noorani T, Rezaei A, Yahyaei B (2017) Biosynthesis of gold nanoparticles by two bacterial and fungal strains, Bacillus cereus and Fusarium oxysporum, and assessment and comparison of their nanotoxicity in vitro by direct and indirect assays. Electron J Biotechnol 29:86–93CrossRefGoogle Scholar
Gwinn MR, Vallyathan V (2006) Nanoparticles: health effects—pros and cons. Environ Health Perspect 114:12CrossRefGoogle Scholar
Chen J, Li S, Luo J, Wang R, Ding W (2016) Enhancement of the antibacterial activity of silver nanoparticles against phytopathogenic bacterium Ralstonia solanacearum by stabilization. J Nanomater ID 7135852:15 pages. https://doi.org/10.1155/2016/7135852Google Scholar
Niakan S, Niakan M, Hesaraki S, Nejadmoghaddam MR, Moradi M, Hanafiabdar M, Allamezadeh R, Sabouri M (2013) Comparison of the antibacterial effects of nanosilver with 18 antibiotics on multidrug resistance clinical isolates of Acinetobacter baumannii. Jundishapur J Microbiol 6(5):e8341. https://doi.org/10.5812/jjm.8341CrossRefGoogle Scholar